A grant materials appendix is read as evidence, not as a procurement wishlist. Reviewers and research managers want to see what will be used, why it is suitable, how each item will be identified, and how the record will be kept. A recommended stack may be convenient in a catalogue conversation, but it can blur those points because it groups items under a label rather than naming the sequence, catalogue entry and batch document. For research-only work, build the basket around named sequences and individual vials. State clearly that all materials are for controlled in-vitro laboratory research only, are not medicines, and are not for human or veterinary use.
Begin With the Sequence That a Reviewer Can Trace
What to put in the row
In the appendix, each row should begin with the exact product name, catalogue reference and quantity that will be requested. For example, list Ipamorelin 5mg and CJC-1295 (No DAC) 5mg as separate lines rather than grouping them under a colloquial bundle name. The same principle applies to BPC-157 10mg, TB-500 5mg, GHK-Cu 50mg or any other catalogue entry you actually intend to use. The purpose is not to make the appendix look fuller; it is to make each material traceable to a specific vial, batch and documented research justification.
A named-sequence approach also keeps the study design honest. If two or more peptides are required, describe them as separate experimental factors or separate treatment arms, with their own controls and analysis plan. Research Sciences states that it does not supply blended peptides and recommends buying peptides individually, combining only within a controlled experimental design. That fits grant writing well: the appendix can show individual lines, individual CoAs and a clear rationale for any combined laboratory exposure. It avoids the vague phrase “recommended stack”, which suggests a ready-made formula rather than a set of research materials chosen for a defined in-vitro assay.
Use the materials section to connect each named sequence to a measurable laboratory task. A reviewer should be able to see whether the item is a study compound, an analytical reference, a control or part of method development. Keep the language in-vitro and research-use-only throughout. Do not describe outcomes in health, performance or therapeutic terms. Instead, write that the vial supports a specified assay, signalling study or analytical run within the approved laboratory protocol. If a catalogue example such as MT-1 10mg or Tesamorelin 5mg appears, it should appear because the protocol needs that named item, not because it is part of a generic bundle.
Attach Batch-Level Documentation to Every Named Item
The CoA column
The appendix should carry a documentation column for every named sequence. Research Sciences describes a Certificate of Analysis for every product, with HPLC used for purity and identity, and full-spectrum testing described as purity, identity, heavy metals and endotoxin evaluation of submitted samples. The homepage also lists “CoAs Janoshik Analytical Reports”. Treat those as the shop’s current published wording and reconfirm the actual batch CoA before submission. Do not invent pass/fail limits, certificate numbers or a single reconciled purity figure. If the catalogue states a purity headline, the exact value for the supplied batch should be checked on the CoA that accompanies that specific vial.
Record the label reference in the appendix where possible. The site describes a reference format combining SKU code and expiry date, such as BPC10-03/27, which links to the corresponding CoA. A row that reads “BPC-157 10mg — label BPC10-03/27 — CoA checked on receipt” is more useful to a materials manager than “peptide bundle”. If restocked products carry the same Internal Test Reference, remember the shop’s FAQ position: an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Cap colour and packaging may vary and are not indicators of identity, analytical quality or manufacturing origin.
Where formulation matters to the assay, note that the FAQs state all peptides contain trace amounts of mannitol as an excipient. Keep that factual and laboratory-focused; do not turn it into a therapeutic claim. The appendix should also show storage expectations and the CoA reference together, so that a reviewer can see the documentation trail from named sequence to batch record. A grant file does not need promotional language. It needs clear evidence that each item can be checked against the batch document, the label and the laboratory’s internal receipt record.
Build the Basket Around Laboratory Workflow, Not a Bundle
Storage and in-vitro handling
For each named sequence, record the quantity, storage condition and laboratory-use purpose. The shop’s handling guidance says lyophilised peptides should be stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light. Avoid repeated freeze–thaw cycles. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. Vials should be allowed to reach room temperature before opening, and work should take place in a clean environment with only the amount required for the experiment removed. These are laboratory workflow notes, not clinical instructions, and all materials remain not for human or veterinary use.
If the appendix mentions reconstitution, keep it strictly in-vitro: diluent volume, final concentration for the assay, and the solvent supplied separately. The free peptide reconstitution calculator described on product pages and in the FAQs is for laboratory research use only and must not be used for human or veterinary dosing. A grant materials appendix should not read like a protocol for administration. It should read like a record of how a named research reagent will be prepared for a controlled in-vitro experiment, with the calculation checked by the responsible researcher and retained with the study file.
Procurement details belong in the appendix only where they affect feasibility. Research Sciences states that orders are dispatched the next working day and shipped via Royal Mail Tracked 24, which usually delivers the following working day according to the Royal Mail estimate; tracking is provided after dispatch, and delivery times may vary in peak periods. The homepage “24hr UK Delivery” line should not be rewritten as a guaranteed next-day arrival. Reconfirm current fulfilment and returns wording at the time of ordering. A practical way to start is to review the current catalogue entry for each named sequence and then open the individual product page and batch CoA; the all-products listing is available via Buy peptides uk. Keep separate lines for each vial, batch reference and storage note, and remove any stack label before the appendix is signed off.
